Psychedelics, Menstrual Cycles, and Female Mental Health: Why Hormonal Awareness Matters

Turning to psychotropic drugs to alleviate mental health concerns can be daunting—even when done under professional supervision. Add psychedelics and the promise of a life-altering experience, and it’s natural for most people to feel nervous.

One of the most widely agreed-upon principles in psychedelic research is the importance of “set and setting”: the mindset one brings into the experience and the physical environment in which it occurs. But for women, a critical component of mindset—the reproductive cycle—is often overlooked, despite its significant influence on mood and mental health.

Understanding the Female Menstrual Cycle

The menstrual cycle is a defining physiological difference between men and women, spanning roughly ages 13 to 50. Key phases include:

• Menstruation – marks the start of the cycle.

• Follicular phase – the egg develops and is released around day 14.

• Luteal phase – post-ovulation; if fertilization does not occur, the uterine lining sheds, triggering the next period.

The full cycle typically lasts 21–35 days in healthy populations.

Hormonal Fluctuations and Daily Life

Hormone shifts during the menstrual cycle, particularly estrogen and progesterone, impact:

• Mood and emotional regulation

• Energy levels

• Sleep quality

• Digestion

• Physical pain (breasts, lower abdomen, and back)

Women may also experience hormonal disturbances due to birth control, pregnancy, menopause, or reproductive disorders such as endometriosis, PCOS, and PMDD, all of which affect progesterone balance and overall hormone production.

Estrogen and Mental Health

Research shows that imbalances in estrogen can reduce dopamine sensitivity, making women more vulnerable to depression, psychosis, and other mental health challenges (Arad & Weiner, 2010). Estrogen naturally fluctuates during the menstrual cycle, which can influence mental health outcomes:

• 26% increase in suicide deaths

• 17% increase in suicide attempts

• 20% increase in psychiatric admissions

These risks are highest during menstruation, when estrogen levels are lowest (Jang & Elfenbein, 2019).

Psychedelics and the Menstrual Cycle

Current psychedelic research rarely accounts for female reproductive cycles, yet there is evidence suggesting a link between psychedelics and menstrual health. Case reports by Gukasyan & Narayan (2022) documented improved menstrual regularity in women following experiences with psychedelic compounds.

One hypothesis is that a positive psychedelic experience may reduce stress hormones, indirectly supporting hormone balance and improving menstrual health.

Why Female-Specific Set and Setting Matters

Ignoring menstrual cycles and hormonal fluctuations in psychedelic research risks misrepresenting female experiences and potentially harming participants. Women’s mood, sensitivity, and overall mental health are deeply intertwined with hormonal cycles.

By incorporating menstrual cycle awareness into psychedelic research and therapy, scientists and practitioners can:

• Enhance female-specific safety and efficacy

• Understand the interaction between psychedelics and hormone-driven mood changes

• Explore potential therapeutic effects on hormone-related mental health challenges

Conclusion

Accounting for the menstrual cycle in psychedelic experiences is not optional—it is essential for safe, effective, and female-centered mental health care. This approach offers the potential to both improve mental health outcomes and uncover the ways psychedelics may interact with female biology to support hormonal and psychological balance.

References

Arad, M., & Weiner, I. (2010). Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17β-estradiol: an animal model of menopausal psychosis?. Neuropsychopharmacology, 35(7), 1570–1582.

Jang, D., & Elfenbein, H. A. (2019). Menstrual cycle effects on mental health outcomes: a meta-analysis. Archives of Suicide Research, 23(2), 312–332.

Gukasyan, N., & Narayan, S. K. (2022). Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series. Journal of Psychoactive Drugs, 1–6.